These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23076934)

  • 1. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R; Lawrie TA
    Cochrane Database Syst Rev; 2012 Jul; 7(7):CD007102. PubMed ID: 22786502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
    Deng L; Zhang J; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD005196. PubMed ID: 23440800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First line chemotherapy in low risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for high-risk gestational trophoblastic tumour.
    Deng L; Yan X; Zhang J; Wu T
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005196. PubMed ID: 19370618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for high-risk gestational trophoblastic tumour.
    Xue Y; Zhang J; Wu TX; An RF
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005196. PubMed ID: 16856085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of prophylactic chemotherapy in treating with hydatidiform mole: A protocol for systematic review and meta-analysis.
    Xu F; Zheng YL; Lu XY; Qiao HF; Wang Y
    Medicine (Baltimore); 2021 Jun; 100(24):e26341. PubMed ID: 34128882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.
    Albright BB; Ellett T; Knochenhauer HE; Goins EC; Monuszko KA; Kaplan SJ; Previs RA; Moss HA; Havrilesky LJ; Davidson BA
    BJOG; 2023 Apr; 130(5):443-453. PubMed ID: 36648416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia.
    Liu Y; Ye Y; Cheng X; Lu W; Xie X; Wang X; Li X
    BMC Womens Health; 2023 Jan; 23(1):1. PubMed ID: 36593459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Chemotherapy with Methotrexate Leucovorin in High-Risk Hydatidiform Mole.
    Aminimoghaddam S; Mahmoudzadeh F; Mohammadi M
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1755-1758. PubMed ID: 32592374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.